filed by bristol-myers squibb companyd18rn0p25nwr6d.cloudfront.net/cik-0000014272/9909e384-c...filed...
Post on 28-Aug-2020
1 Views
Preview:
TRANSCRIPT
Filed by Bristol-Myers Squibb CompanyPursuant to Rule 425 of the Securities Act of 1933
and deemed filed pursuant to Rule 14a-12of the Securities Exchange Act of 1934
Form S-4 File No.: 333-229464Subject Company: Celgene Corporation
SEC File No.: 001-34912Explanatory Note: The following slides were used by Bristol-Myers Squibb Company at an investor presentation on February 20, 2019.
top related